Tanja Potpara, EHRA 2022: NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication
Dr Tanja Potpara (Belgrade University School of Medicine, Belgrade, Serbia) kindly discussed with us her presentation on the journey of patients on novel oral anticoagulants (NOACs), which was presented during a session on atrial fibrillation clinical cases with focus on rhythm control and anticoagulation at this years EHRA.
‘NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication‘ was presented at EHRA 2022, 03-05 April, 2022.
Questions
- What did your presentation raise regarding the management of patients with atrial fibrillation after acute coronary syndrome and/or percutaneous coronary intervention? (0:21)
- What issues were raised in terms of dosage in renal dysfunction and the concurrent use of other medications? (7:07)
- What were the key take-home messages of the presentation? (9:05)
Disclosures: Tatjana Potpara has nothing to disclose in relation to this video
Support:Â Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the annual EHRA Conference 2022.
